X-Linked Lymphoproliferative Disorder
|
0.330 |
Biomarker
|
disease |
CTD_human |
Inorganic arsenic represses interleukin-17A expression in human activated Th17 lymphocytes.
|
22617429 |
2012 |
Vomiting
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.
|
3091246 |
1986 |
Urban cutaneous leishmaniasis
|
0.310 |
Biomarker
|
disease |
CTD_human |
Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds.
|
8154019 |
1994 |
Urban cutaneous leishmaniasis
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
|
20102417 |
2010 |
Urban cutaneous leishmaniasis
|
0.310 |
Biomarker
|
disease |
CTD_human |
Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors.
|
20102417 |
2010 |
Urban cutaneous leishmaniasis
|
0.310 |
Biomarker
|
disease |
CTD_human |
Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.
|
9234779 |
1997 |
Urban cutaneous leishmaniasis
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Successful therapy of chronic, nonhealing murine cutaneous leishmaniasis with sodium stibogluconate and gamma interferon depends on continued interleukin-12 production.
|
9234779 |
1997 |
Urban cutaneous leishmaniasis
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Clinical healing of antimony-resistant cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-gamma and pentavalent antimonial compounds.
|
8154019 |
1994 |
Unipolar Depression
|
0.330 |
Biomarker
|
disease |
PSYGENET |
Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene.
|
23597432 |
2013 |
TUBEROUS SCLEROSIS 2 (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Tuberous Sclerosis
|
0.300 |
Therapeutic
|
disease |
CTD_human |
The cytokine interferon-gamma (IFN-gamma) is another potential therapeutic agent for TSC.
|
16845661 |
2006 |
Toxic Epidermal Necrolysis
|
0.330 |
Biomarker
|
disease |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Tethered Cord Syndrome
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
|
17075842 |
2006 |
Streptozotocin Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.
|
21340626 |
2011 |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Stevens-Johnson Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
|
25811541 |
2015 |
Spinal Cord Myelodysplasia
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Valproic acid-induced fetal malformations are reduced by maternal immune stimulation with granulocyte-macrophage colony-stimulating factor or interferon-gamma.
|
17075842 |
2006 |
Severe Sepsis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation.
|
9806674 |
1998 |
Septicemia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation.
|
9806674 |
1998 |
Sepsis
|
0.600 |
Biomarker
|
disease |
CTD_human |
Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation.
|
9806674 |
1998 |
Secondary Peritonitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Glucans from the Caripia montagnei mushroom present anti-inflammatory activity.
|
19804847 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
To characterize the activation status of the immune system in schizophrenia, we examined the pattern of gene expression in peripheral blood cells for three Th1 cytokines (interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2)), and one Th2 cytokine (interleukin-10 (IL-10)).
|
20132993 |
2010 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Paradoxical downregulation of HLA-A expression by IFNγ associated with schizophrenia and noncoding genes.
|
23083632 |
2013 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
In order to explore the possible relationship between IFNG and schizophrenia, we attempted to analyze the differentially expressed proteins in the brains of interferon-gamma knockout (Ifng-KO) mice.
|
22623148 |
2012 |
Sarcoma, Spindle Cell
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Clinical applications of TNF-alpha in cancer.
|
9794839 |
1998 |